The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Practice · Dosing & titration

The arithmetic of an intermediate dose between two label steps

MH
m.haddadTL2Regular18 May 2026#1

On the subject in the title: The arithmetic of an intermediate dose between two label steps Working notes rather than a conclusion.

I have read the maintained page on this and I still have a gap, so I am asking rather than guessing.

Context: retatrutide, 20 weeks in, currently at a dose I reached by the standard four-week steps. Everything below is my own record rather than anything a clinician told me.

The specific question is the one in the title. What I have already checked: the labelling summary on the relevant documentation page, the two most-linked topics in this subcategory, and my own notes from the last 9 weeks. What I could not find is whether the answer changes at higher doses or whether it is the same arithmetic throughout.

If the answer is "it depends", I would rather know what it depends on than be given a number.

17 likes 2mo
JH
j.habermannTL3Regular21 May 2026#2

The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat it as one.

I have changed my mind on this once already, so take it as current rather than settled.

21 likes 2mo
CB
c.balogunTL223 May 2026 · edited#3

Acknowledging rather than arguing. The reasoning holds as far as I can follow it.

0 likes 2mo
Moved from Reconstitution by KLindqvist. Category placement is not obvious from outside and getting it wrong is expected. This topic will get better answers here. The move is recorded in the public log citing R7.

Suggested topics

TopicParticipantsRepliesViewsActivity
Restarting after a long gap: what the labelling implies — the long version
Restarting after a long gap: what the labelling implies — the long version Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
OFDIBRMHF+12 17 2.4k 2mo
Dose numbers across compounds are not on the same scale
Dose numbers across compounds are not on the same scale — setting out what I have, and where I think it stops being reliable. I would like to disagree carefully with the settled view on dose numbers across…
BPISC 2 1.6k 9mo
Escalating every six weeks instead of four: what I observed over eight months
Escalating every six weeks instead of four: what I observed over eight months Writing it up because I had to work it out twice and would rather nobody else did. Asking about escalating every six weeks instead…
RMKCCLHETP+27 31 432 18mo
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept I have read the maintained page on this and I still have a gap, so I…
BWSANTIRSS+7 11 26k 9mo
Reaching a dose and staying there for a year: a longitudinal note
Reaching a dose and staying there for a year: a longitudinal note Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have a…
RFNRHC 2 763 15mo

Related topics — sharing the tags dose reduction, semaglutide, missed dose

TopicParticipantsRepliesViewsActivity
Rotating between abdomen, thigh and upper arm: absorption differences — one year on
Rotating between abdomen, thigh and upper arm: absorption differences — one year on — setting out what I have, and where I think it stops being reliable. Asking about Rotating between abdomen directly,…
ITTTBCSTN+82 102 24k just now
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept
Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept I have read the maintained page on this and I still have a gap, so I…
BWSANTIRSS+7 11 26k 9mo
About the Semaglutide category
GLP-1 receptor agonist. Dosing, published trial data, tolerability, and formulation questions. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
TVJMRJGOMH 4 4.2k 11mo
Rotating between abdomen, thigh and upper arm: absorption differences
On the subject in the title: Rotating between abdomen, thigh and upper arm: absorption differences Working notes rather than a conclusion. Asking about rotating between abdomen directly, because I have read…
WTNZED 2 3.5k 5mo
Drawing up with one needle and injecting with another
On the subject in the title: Drawing up with one needle and injecting with another Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing the same thing…
KFIDFIOCH+1 5 6.9k 1d